Presentation is loading. Please wait.

Presentation is loading. Please wait.

Vasiliki V. Georgiopoulou, MD, Andreas P. Kalogeropoulos, MD, Bruce M

Published byMiloslav Dvořák Modified over 6 years ago

Similar presentations

Presentation on theme: "Vasiliki V. Georgiopoulou, MD, Andreas P. Kalogeropoulos, MD, Bruce M"— Presentation transcript:

1 Lung Function and Risk for Heart Failure Among Older Adults: The Health ABC Study 
Vasiliki V. Georgiopoulou, MD, Andreas P. Kalogeropoulos, MD, Bruce M. Psaty, MD, PhD, Nicolas Rodondi, MD, MAS, Douglas C. Bauer, MD, Abida B. Butler, MD, Annemarie Koster, PhD, Andrew L. Smith, MD, Tamara B. Harris, MD, MS, Anne B. Newman, MD, MPH, Stephen B. Kritchevsky, PhD, Javed Butler, MD, MPH  The American Journal of Medicine  Volume 124, Issue 4, Pages (April 2011) DOI: /j.amjmed Copyright © 2011 Elsevier Inc. Terms and Conditions

2 Figure 1 Flowchart of participant selection for the current analysis.
The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2011 Elsevier Inc. Terms and Conditions

3 Figure 2 Annualized risk of incident heart failure for participants with normal versus abnormal lung function tests at baseline, adjusted for predictors of heart failure and body mass index. Smoothed hazard estimate was obtained using an Epanechnikov kernel. Although the absolute annualized risk increases from year 1 to year 5 before reaching a plateau in both groups, the relative risk remains stable over time. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2011 Elsevier Inc. Terms and Conditions

4 Figure 3 Kaplan-Meier rates of incident heart failure by baseline lung function status in sex and race subgroups, adjusted for predictors of heart failure and body mass index. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2011 Elsevier Inc. Terms and Conditions

5 Figure 4 Unadjusted incident heart failure rates according to baseline forced expiratory volume in 1st second (FEV1) and forced vital capacity (FVC) values. Rates are expressed in cases per 1000 person-years. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2011 Elsevier Inc. Terms and Conditions

Download ppt "Vasiliki V. Georgiopoulou, MD, Andreas P. Kalogeropoulos, MD, Bruce M"

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Andrew Moran, MD, MPH, Ronit Katz, PhD, Nicolas L. Smith, PhD, Linda F

Andrew Moran, MD, MPH, Ronit Katz, PhD, Nicolas L. Smith, PhD, Linda F
Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 
New-onset Atrial Fibrillation Predicts Heart Failure Progression

New-onset Atrial Fibrillation Predicts Heart Failure Progression
Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey  Bartolome R. Celli, MD, R.J. Halbert, MD,

Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey  Bartolome R. Celli, MD, R.J. Halbert, MD,
Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 
Grip Strength Predicts Cause-Specific Mortality in Middle-Aged and Elderly Persons  Hideo Sasaki, MD, PhD, Fumiyoshi Kasagi, PhD, Michiko Yamada, MD, PhD,

Grip Strength Predicts Cause-Specific Mortality in Middle-Aged and Elderly Persons  Hideo Sasaki, MD, PhD, Fumiyoshi Kasagi, PhD, Michiko Yamada, MD, PhD,
An Unusual Cause of Leg Ulcerations

An Unusual Cause of Leg Ulcerations
The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study  Ido Weinberg, Philimon Gona, Christopher.

The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study  Ido Weinberg, Philimon Gona, Christopher.
Aruna D. Pradhan, MD, Nader Rifai, PhD, Julie E. Buring, ScD, Paul M

Aruna D. Pradhan, MD, Nader Rifai, PhD, Julie E. Buring, ScD, Paul M
A Clinical Study of COPD Severity Assessment by Primary Care Physicians and Their Patients Compared with Spirometry  Douglas W. Mapel, MD, MPH, Anand.

A Clinical Study of COPD Severity Assessment by Primary Care Physicians and Their Patients Compared with Spirometry  Douglas W. Mapel, MD, MPH, Anand.
Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure
Tim McAlindon, MD, MPH, Margaret Formica, MSPH, Christopher H

Tim McAlindon, MD, MPH, Margaret Formica, MSPH, Christopher H
Phosphorus and Risk of Renal Failure in Subjects with Normal Renal Function  John J. Sim, MD, Simran K. Bhandari, MD, Ning Smith, PhD, Joanie Chung, MS,

Phosphorus and Risk of Renal Failure in Subjects with Normal Renal Function  John J. Sim, MD, Simran K. Bhandari, MD, Ning Smith, PhD, Joanie Chung, MS,
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure  Jacques D. Donzé, MD, MSc, Patrick.

Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure  Jacques D. Donzé, MD, MSc, Patrick.
Leslie R. Harrold, MD, MPH, Daniel Peterson, MS, Ashley J

Leslie R. Harrold, MD, MPH, Daniel Peterson, MS, Ashley J
Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment?∗ ∗2  Douglas E Mesler, MD, MPH, Ellen P McCarthy, PhD, Susan.

Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment?∗ ∗2  Douglas E Mesler, MD, MPH, Ellen P McCarthy, PhD, Susan.
CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation  Walid Saliba, MD, MPH, Gad Rennert,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation  Walid Saliba, MD, MPH, Gad Rennert,

Similar presentations

Ads by Google